Michael Gelband’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-44,615
| Closed | -$11.9M | – | 1630 |
|
|
2026
Q1 | $11.9M | Buy |
44,615
+23,780
| +114% | +$6.58M | 0.09% | 196 |
|
|
2025
Q4 | $5.73M | Sell |
20,835
-13,929
| -40% | -$3.9M | 0.05% | 427 |
|
|
2025
Q3 | $10M | Buy |
34,764
+1,534
| +5% | +$454K | 0.1% | 201 |
|
|
2025
Q2 | $11M | Sell |
33,230
-6,481
| -16% | -$2.09M | 0.1% | 206 |
|
|
2025
Q1 | $13.1M | Buy |
39,711
+17,095
| +76% | +$5.15M | 0.13% | 160 |
|
|
2024
Q4 | $6.25M | Buy |
22,616
+11,641
| +106% | +$3.71M | 0.04% | 388 |
|
|
2024
Q3 | $3.8M | Sell |
10,975
-60,631
| -85% | -$20.9M | 0.02% | 511 |
|
|
2024
Q2 | $23.7M | Buy |
+71,606
| New | +$24.7M | 0.16% | 107 |
|
|
2024
Q1 | – | Sell |
-71,105
| Closed | -$21.3M | – | 1536 |
|
|
2023
Q4 | $21.3M | Sell |
71,105
-743
| -1% | -$217K | 0.14% | 94 |
|
|
2023
Q3 | $20.6M | Buy |
71,848
+31,341
| +77% | +$8.94M | 0.2% | 93 |
|
|
2023
Q2 | $11.4M | Sell |
40,507
-91,253
| -69% | -$23.8M | 0.09% | 220 |
|
|
2023
Q1 | $33.7M | Buy |
+131,760
| New | +$38.4M | 0.28% | 44 |
|
|
2022
Q4 | – | Sell |
-19,356
| Closed | -$5.37M | – | 1695 |
|
|
2022
Q3 | $5.37M | Sell |
19,356
-12,447
| -39% | -$3.5M | 0.07% | 378 |
|
|
2022
Q2 | $8.38M | Buy |
31,803
+6,643
| +26% | +$1.71M | 0.1% | 232 |
|
|
2022
Q1 | $6.03M | Buy |
25,160
+77
| +0.3% | +$18K | 0.08% | 324 |
|
|
2021
Q4 | $5.76M | Buy |
25,083
+4,456
| +22% | +$947K | 0.06% | 383 |
|
|
2021
Q3 | $4.13M | Sell |
20,627
-9,538
| -32% | -$2.07M | 0.06% | 466 |
|
|
2021
Q2 | $7.15M | Buy |
30,165
+26,212
| +663% | +$6.55M | 0.08% | 224 |
|
|
2021
Q1 | $956K | Sell |
3,953
-305
| -7% | -$68K | 0.01% | 944 |
|
|
2020
Q4 | $886K | Sell |
4,258
-5,317
| -56% | -$1.04M | 0.01% | 919 |
|
|
2020
Q3 | $1.62M | Buy |
9,575
+5,035
| +111% | +$886K | 0.03% | 472 |
|
|
2020
Q2 | $852K | Buy |
4,540
+2,711
| +148% | +$514K | 0.02% | 824 |
|
|
2020
Q1 | $324K | Sell |
1,829
-9,770
| -84% | -$1.9M | 0.02% | 630 |
|
|
2019
Q4 | $2.37M | Buy |
11,599
+3,523
| +44% | +$646K | 0.04% | 301 |
|
|
2019
Q3 | $1.23M | Buy |
8,076
+6,716
| +494% | +$1.09M | 0.04% | 338 |
|
|
2019
Q2 | $214K | Buy |
+1,360
| New | +$213K | 0.01% | 889 |
|
Other funds holding CI
Michael Gelband's CI Position: Q2 2026 in Review
Michael Gelband sold out of Cigna (CI) in Q2 2026, closing a stake of 44,615 shares — an estimated $11.9M sold.
Michael Gelband first reported a position in CI in Q2 2019 and held it in 26 quarters. The position peaked at $33.7M in Q1 2023. 1,690 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Michael Gelband reported no remaining Cigna position as of Q2 2026 after selling out during the quarter.
- Michael Gelband sold 44,615 Cigna shares in Q2 2026, an estimated $11.9M.
- Michael Gelband first reported a position in Cigna in Q2 2019 and held it in 26 quarters.
- Michael Gelband's Cigna position peaked at $33.7M in Q1 2023.
- 1,690 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.